CiteScore: 5.0     h-index: 22

Document Type : Original Research Article

Authors

1 Department of Pharmaceutical Chemistry, Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Premnagar, Dehradun-248007, Uttarakhand, India

2 School of Agriculture, Uttaranchal University, Dehradun, Uttarakhand, India

3 Laboratory of Carbohydrate and Nucleoside Chemistry, Department of Chemistry, Faculty of Science, University of Chittagong, Chittagong 4331, Bangladesh

Abstract

A newer generation pyrimidine derivatives were designed, synthesized, and evaluated in vitro alpha amylase and bacterial growth inhibitor. The molecules' design fully depended upon the structural features of previously pyrimidine derivatives. Then all the designed molecules (SD1-SD100) were docked with 1OSE pig pancreatic alpha-amylase isoenzyme. S-[4-(2-hydroxyphenyl)-6-phenylpyrimidin-2-yl] benzenecarbothioate, S-(4,6-diphenylpyrimidin-2-yl) benzenecarbothioate, S-[4-(4-hydroxy-3-methoxyphenyl)-6-phenylpyrimidin-2-yl] benzenecarbothioate, and S-[4,6-bis(4-hydroxyphenyl)pyrimidin-2-yl] benzenecarbothioate showed good docking interaction scores, as compared to acarbose. The interacting residues of the synthesized molecules and 1OSE showed similar amino acid lining as present in the active site. The synthetic procedure of the molecules was divided into two steps such as synthesis of chalcone derivative using aromatic aldehyde and acetophenone, reaction between chalcone and thiourea to form substituted pyrimidine-2-thiol, then finally substituted pyrimidine-2-thiol and benzoyl chloride reacted in presence of glacial acetic acid to obtain the best docked molecules. All the molecules show characteristic peaks in FTIR, 1H-NMR and Mass spectrometric data. Among all the synthesized molecules S-[4-(2-hydroxyphenyl)-6-phenylpyrimidin-2-yl] benzenecarbothioate showed best in vitro alpha amylase inhibition activity. Also, all synthesized molecules showed moderate to good antibacterial activities.

Graphical Abstract

Molecular Docking, Synthesis, In-vitro Alpha Amylase and Antibacterial Activities of Newer Generation Pyrimidine Derivatives

Keywords

Main Subjects

OPEN ACCESS

©2024 The author(s). This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit: http://creativecommons.org/licenses/by/4.0/

PUBLISHER NOTE

Sami Publishing Company remains neutral concerning jurisdictional claims in published maps and institutional affiliations.

CURRENT PUBLISHER

Sami Publishing Company

[1] H.S. Mohamed, Z.S. Hamza, A.M. Nagdy, H.R. Abd El-Mageed, Calculations of synthesized triazolo pyrimidine derivatives: A review, Journal of Chemical Reviews, 2022, 4, 156-190. [Crossref], [Google Scholar], [Publisher]
[2] H.S.H. Mohamed, S.A. Ahmed, Reviewing of synthesis and computational studies of pyrazolo pyrimidine derivatives, Journal of Chemical Reviews, 2019, 1, 154-251. [Crossref], [Google Scholar], [Publisher]
[3] M.J. Ramaiah, A.D. Tangutur, R.R. Manyam, Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy, Life Sciences, 2021, 277, 119504. [Crossref], [Google Scholar], [Publisher]
[4] A.D. Bondarev, M.M. Attwood, J. Jonsson, V.N. Chubarev, V.V. Tarasov, H.B. Schiöth, Recent developments of HDAC inhibitors: Emerging indications and novel molecules, British Journal of Clinical Pharmacology, 2021, 87, 4577-4597. [Crossref], [Google Scholar], [Publisher]
[5] G. Shanmugam, S. Rakshit, K. Sarkar, HDAC inhibitors: Targets for tumor therapy, immune modulation and lung diseases, Translational Oncology, 2022, 16, 101312. [Crossref], [Google Scholar], [Publisher]
[6] M. Manuel, A. Jennifer, A review on starch and cellulose-enhanced superabsorbent hydrogel, Journal of Chemical Reviews, 2023, 5, 183-203. [Crossref], [Google Scholar], [Publisher]
[7] S. Akter, B.Y. Alhatlani, E.M. Abdallah, S. Saha, J. Ferdous, M.E. Hossain, F. Ali, S.M. Kawsar, Exploring cinnamoyl-substituted mannopyranosides: Synthesis, evaluation of antimicrobial properties, and molecular docking studies rargeting H5N1 influenza a Virus, Molecules, 2023, 28, 8001. [Crossref], [Google Scholar], [Publisher]
[8] K.B. Lokhande, A. Tiwari, S. Gaikwad, S. Kore, N. Nawani, M. Wani, K.V. Swamy, S.V. Pawar, Computational docking investigation of phytocompounds from bergamot essential oil against Serratia marcescens protease and FabI: Alternative pharmacological strategy, Computational Biology and Chemistry, 2023, 104, 107829. [Crossref], [Google Scholar], [Publisher]
[9] S. Nagare, K.B. Lokhande, K.V. Swamy, Molecular docking and simulation studies of flavanone and its derived compounds on PI3K-AKT pathway targeting against cancer, Current Drug Discovery Technologies, 2023, 20, 21-29. [Crossref], [Google Scholar], [Publisher]
[10] S. Saha, D. Pal, S. Kumar, Design, synthesis and antiproliferative activity of hydroxyacetamide derivatives against HeLa cervical carcinoma cell and breast cancer cell line, Tropical Journal of Pharmaceutical Research, 2016, 15, 1401-1411. [Crossref], [Google Scholar], [Publisher]
[11] C. Gilles, J.P. Astier, G. Marchis‐Mouren, C. Cambillau, F. Payan, Crystal structure of pig pancreatic α‐amylase isoenzyme II, in complex with the carbohydrate inhibitor acarbose, European Journal of Biochemistry, 1996, 238, 561-569. [Crossref], [Google Scholar], [Publisher]
[12] T.D. Gross, Y.F. Zhu, J. Saunders, K.M. Wilcoxen, Y. Gao, P.J. Connors Jr, Z. Guo, R.S. Struthers, G.J. Reinhart, C. Chen, Design, synthesis and structure–Activity relationships of novel imidazolo [1, 2-a] pyrimid-5-ones as potent GnRH receptor antagonists, Bioorganic & medicinal chemistry letters, 2002, 12, 2185-2187. [Crossref], [Google Scholar], [Publisher]
[13] Y. Zheng, J. Tian, W. Yang, S. Chen, D. Liu, H. Fang, H. Zhang, X. Ye, Inhibition mechanism of ferulic acid against α-amylase and α-glucosidase, Food Chemistry, 2020, 317, 126346. [Crossref], [Google Scholar], [Publisher]
[14] X. Peng, K. Liu, X. Hu, D. Gong, G. Zhang, Hesperetin-Cu (II) complex as potential α-amylase and α-glucosidase inhibitor: Inhibition mechanism and molecular docking, Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2023, 290, 122301. [Crossref], [Google Scholar], [Publisher]
[15] M. Almehmadi, A.A. Alsaiari, M. Allahyani, A. Alsharif, A. Aljuaid, S. Saha, M. Asif, Computational studies and antimicrobial activity of 1-(benzo [d] oxazol-2-yl)-3, 5-diphenylformazan derivatives, Current Computer-aided Drug Design, 2023. [Crossref], [Google Scholar], [Publisher]
[16] M.R. Kayes, S. Saha, M.M. Alanazi, Y. Ozeki, D. Pal, T.B. Hadda, A. Legssyer, S.M. Kawsar, Macromolecules: Synthesis, antimicrobial, POM analysis and computational approaches of some glucoside derivatives bearing acyl moieties, Saudi Pharmaceutical Journal, 2023, 31, 101804. [Crossref], [Google Scholar], [Publisher]
[17] S.M. Kawsar, N.S. Munia, S. Saha, Y. Ozeki, In silico pharmacokinetics, molecular docking and molecular dynamics simulation studies of nucleoside analogs for drug discovery-a mini review, Mini Reviews in Medicinal Chemistry, 2023. [Google Scholar], [Publisher]
[18] S. Saha, V.J. Prinsa, A.K. Mahato, S. Srivastava, K. Dobhal, S.M. Kawsar, In silico assessment of the role of iridoid in the treatment of zika and influenza virus infection, Philippine Journal of Science, 2023, 152, 1953-1988. [Google Scholar]
[19] W. Ahmad, K. Kumar Jaiswal, M. Amjad, Euphorbia herita leaf extract as a reducing agent in a facile green synthesis of iron oxide nanoparticles and antimicrobial activity evaluation, Inorganic and Nano-Metal Chemistry, 2021, 51, 1147-1154. [Crossref], [Google Scholar], [Publisher]
[20] S.S. Sana, D.V. Kumbhakar, A. Pasha, S.C. Pawar, A.N. Grace, R.P. Singh, V.-H. Nguyen, Q.V. Le, W. Peng, Crotalaria verrucosa leaf extract mediated synthesis of zinc oxide nanoparticles: assessment of antimicrobial and anticancer activity, Molecules, 2020, 25, 4896. [Crossref], [Google Scholar], [Publisher]
[21] B.O. Ajiboye, H.O.B. Oloyede, M.O. Salawu, Antidiabetic activity of triticum aestivum seed-based diet on alloxan-induced diabetic rats, Journal of Dietary Supplements, 2020, 17, 133-149. [Crossref], [Google Scholar], [Publisher]